Skip to main content
. 2021 Feb 12;11:589114. doi: 10.3389/fphar.2020.589114

FIGURE 1.

FIGURE 1

Liraglutide mitigated high glucose-induced RGCs injuries in vitro. As shown in the figure, RGCs were treated with different concentrations of glucose (25, 40, 65, 80, 95, 110 mmol/L) and different doses of liraglutide (0, 1, 10, 50, 100, 500, and 1000 nmol/L) for 24 h (A–C) Cell viability was detected with CCK-8 assay kits. Values are presented as mean ± SEM. n = 3 independent experiments. *p < 0.05, ***p < 0.001.